Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...
Prilenia Therapeutics B.V., a biopharmaceutical company focused on developing novel therapeutics to treat neurodegenerative ...
The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...
Q3 2024 Earnings Call Transcript November 4, 2024 Operator: Welcome to BioNTech’s Third Quarter 2024 Earnings Call. I would like to hand the call over to Michael Horowicz, Director of Investor ...
A recent study reveals that a polymer called polyphosphate may stabilize fibrils, protein structures linked to Alzheimer's, ...
Former President Donald Trump has boasted in recent months about "Right To Try," a law he signed in 2018. It's aimed at ...
Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...
Watchdog says the recently updated “Declaration of Helsinki” Medical Research Code reinforces experiments on unconsenting ...
A Texas federal district court partly denied Methodist Health System summary judgment on a pregnant clinical research coordinator’s allegations of sex discrimination and FMLA interference, as her ...
Daily Maverick on MSN1d
Women in SA could have access to a three-monthly HIV prevention ring by 2026No further clinical trials are planned for the three-month ring ... Hasina Subedar, a senior technical advisor at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback